sirolimus has been researched along with Angina-Pectoris--Variant* in 2 studies
2 other study(ies) available for sirolimus and Angina-Pectoris--Variant
| Article | Year |
|---|---|
A rare case of Prinzmetal angina 3 days after coronary artery stenting with a second-generation drug-eluting stent.
Topics: Angina Pectoris, Variant; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Stenosis; Coronary Vasospasm; Drug-Eluting Stents; Everolimus; Humans; Male; Middle Aged; Prosthesis Design; Sirolimus; Time Factors; Treatment Outcome; Vasodilator Agents | 2015 |
Intractable Prinzmetal's angina three months after implantation of sirolimus-eluting stent.
Sirolimus-eluting stents (SES) prevent neointimal proliferation and have been widely used to treat stenotic lesions in coronary arteries because of a significant reduction of restenosis in comparison with bare-metal stents. Sirolimus, however, may cause endothelial dysfunction by damage to vascular endothelium or impairing vascular repair. Recent studies report the occurrence of exercise- or acetylcholine-induced coronary vasoconstriction in the vessel segments adjacent to the SES. We report here a clinical case of intractable Prinzmetal's angina 3 months after SES implantation and recommend extended, thorough follow up of patients who have undergone SES implantation. Topics: Adult; Angina Pectoris, Variant; Drug-Eluting Stents; Endothelium, Vascular; Humans; Immunosuppressive Agents; Male; Sirolimus; Time Factors | 2008 |